Comparison

Anti-Human CD44 - Purified (Clone F10-44-2)

Item no. LEIN-C562-0.1mg
Manufacturer Leinco Technologies
Amount 0.1 mg
Category
Type Antibody Monoclonal
Applications FC, IP, IHC
Clone F10-44-2
Specific against Human (Homo sapiens)
Host Mouse
Citations 1. Leukocyte Typing V (1995) Oxford University Press
2. Shi, S. R. et al. (1995) Cell Vision 2:6
3. Stauder, R. et al. (1995) Immunologist 3:78
4. Favaloro, E. (1993) Immunol. Cell Biol. 71:571
5. Goldstein, L. A. et al. (1990) Immunogenetics 32(6):389
6. Leukocyte Typing IV (1989) Oxford University Press
7. Leukocyte Typing III (1987) Oxford University Press
NCBI 960
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping Condition Room temperature
Available
Manufacturer - Targets
 CD44
Country of Origin
USA
Shipping Temperature
Next Day Ambient
Storage Conditions
For use within 1 month of purchase store at 2-8°C. For long term storage freeze working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Background
CD44 is an 80-95 kD glycoprotein that plays a role in various cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. CD44 interacts with osteopontin, collagens, and matrix metalloproteinases (MMPs) and is a receptor for hyaluronic acid. Transcripts for this gene go through intricate alternative splicing that result in a variety of functionally distinct isoforms, including those which may be related to tumor metastasis. These splice variants of CD44 function as receptors under hemodynamic flow conditions that are significant to the development of cancer metastasis. Hence, it is thought that anti-CD44 tumor-specific mAbs may have therapeutic potential. This therapeutic potential of anti-CD44 mAbs is evident in some animal experiments demonstrating a reduction in malignant activities of various neoplasms when CD44 was targeted by a combination of mAbs, antisense oligonucleotides, and CD44-soluble proteins. It has been reported that high levels of CD44 on leukemic cells fuel leukemia production. Notably, various cancer studies show conflicting results pertaining to level of CD44 expression and its correlation with disease prognosis. Before anti-CD44 therapy can be applied to human cancers, it is essential to resolve this inconsistency.
PubMed
CD44
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Manufacturer - Specificity
Clone F10-44-2 recognizes human CD44.
RRID
AB_2829762
Concentration
0.1 mg/ml
Formulation
This purified monoclonal antibody is formulated in phosphate buffered saline (PBS), 1 mg/ml BSA and 10 mM sodium azide as a preservative.
Antigen Distribution
CD44 is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells in addition to B-cells, monocytes, macrophages and certain subsets of thymocytes and peripheral T-cells. Mice with the Ly-24.1 allotype have high densities of CD44+ T-cells.
Immunogen
Purified Human T Cells
Additional Information
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Delivery expected until 12/11/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close